title: Does ovulation induction increase the risk of gynecological cancer?
abstract: The risk of developing gynaecological cancer following ovulation induction therapy in infertile patients is not easy to determine due to many confounding factors. These include the fact that infertility in itself is a known risk factor for some of these cancers, that these patients are subjected to increased surveillance compared to the general population and that the drugs used for ovulation induction are sometimes used in combination. Notwithstanding these limitations, most of the studies have not confirmed a link between these drugs and invasive ovarian cancers, although some studies have suggested that the risk of borderline ovarian tumors may be increased. Investigations regarding breast cancer risk have produced inconsistent results and more information on the subject is warranted. On the contrary, many studies suggest that drugs used for ovulation induction may increase the risk of uterine cancers. More large well-designed studies are still needed to further clarify the effects on cancer risk of these drugs and will allow more in-depth subgroup analysis based on both patient and disease characteristics.
authors.affiliation: Department of Obstetrics and Gynaecology, the University of Alexandria. ; Alexandria Fertility Center.
authors.forename: H N
authors.initials: HN
authors.lastname: Sallam
authors.affiliation: Alexandria Fertility Center.
authors.forename: M
authors.initials: M
authors.lastname: Abdel-Bak
authors.affiliation: Alexandria Regional Center for Women's Health and Development, Alexandria, Egypt.
authors.forename: N H
authors.initials: NH
authors.lastname: Sallam
keywords: HMG; Ovulation induction; breast cancer; cancer; clomiphene citrate; controlled ovarian hyperstimulation; endometrial cancer; gonadotrophins; gynecologic cancer; infertility; ovarian cancer; trophoblastic disease
references.citation: Cancer Lett. 2003 Feb 28;191(1):75-81
references.pmid: 12609712
references.citation: Cancer. 2000 Jun 15;88(12):2845-7
references.pmid: 10870070
references.citation: Obstet Gynecol. 2004 Apr;103(4):785-94
references.pmid: 15051576
references.citation: Lancet. 1999 Nov 6;354(9190):1586-90
references.pmid: 10560672
references.citation: Fertil Steril. 2001 Feb;75(2):305-9
references.pmid: 11172831
references.citation: Fertil Steril. 1996 Jan;65(1):13-8
references.pmid: 8557128
references.citation: Hum Reprod. 1994 Nov;9(11):2010-3
references.pmid: 7532652
references.citation: Br J Obstet Gynaecol. 1982 Feb;89(2):155-9
references.pmid: 6802169
references.citation: Fertil Steril. 1963 Nov-Dec;14:575-95
references.pmid: 14077323
references.citation: Endocrinology. 2006 May;147(5):2338-45
references.pmid: 16484319
references.citation: Am J Epidemiol. 2005 Apr 1;161(7):607-15
references.pmid: 15781949
references.citation: Hum Reprod Update. 2005 Sep-Oct;11(5):439-59
references.pmid: 15923202
references.citation: Hum Reprod. 2001 Nov;16(11):2451-8
references.pmid: 11679537
references.citation: Fertil Steril. 1983 Jul;40(1):23-30
references.pmid: 6407877
references.citation: Int J Gynecol Cancer. 2003 Jan-Feb;13(1):23-7
references.pmid: 12631215
references.citation: Obstet Gynecol. 2004 Jun;103(6):1194-203
references.pmid: 15172852
references.citation: Fertil Steril. 1997 Jun;67(6):1005-12
references.pmid: 9176436
references.citation: Fertil Steril. 2002 Feb;77(2):324-7
references.pmid: 11821091
references.citation: Lancet. 1983 Feb 12;1(8320):357
references.pmid: 6130359
references.citation: Reprod Biomed Online. 2012 Jun;24(6):591-602
references.pmid: 22503948
references.citation: Gynecol Endocrinol. 2007 Jul;23(7):373-6
references.pmid: 17701767
references.citation: Lancet. 1971 Jul 17;2(7716):163
references.pmid: 4104488
references.citation: J Reprod Med. 1988 Jan;33(1):11-6
references.pmid: 3127582
references.citation: Eur J Obstet Gynecol Reprod Biol. 2001 Sep;98(1):53-7
references.pmid: 11516800
references.citation: Fertil Steril. 2013 Aug;100(2):341-8
references.pmid: 23809505
references.citation: Br J Cancer. 2009 Jun 2;100(11):1824-31
references.pmid: 19436296
references.citation: Hum Reprod. 2011 Dec;26(12):3456-65
references.pmid: 22031719
references.citation: Gynecol Oncol. 2001 Jul;82(1):64-8
references.pmid: 11426963
references.citation: Ann Surg Oncol. 2008 Apr;15(4):1048-55
references.pmid: 18214616
references.citation: Fertil Steril. 2011 Sep;96(3):764-8
references.pmid: 21722890
references.citation: Epidemiology. 2005 Jul;16(4):500-7
references.pmid: 15951668
references.citation: Am J Epidemiol. 1998 Jun 1;147(11):1038-42
references.pmid: 9620047
references.citation: Fertil Steril. 1998 Dec;70(6):1049-55
references.pmid: 9848294
references.citation: Gynecol Endocrinol. 2012 Oct;28(10):809-14
references.pmid: 22475084
references.citation: Am J Epidemiol. 2009 Feb 1;169(3):365-75
references.pmid: 19037008
references.citation: Hum Reprod Update. 2004 Nov-Dec;10(6):453-67
references.pmid: 15388674
references.citation: Int J Fertil. 1975;20(1):41-3
references.pmid: 4384
references.citation: Hum Reprod. 2002 Jun;17(6):1610-5
references.pmid: 12042286
references.citation: Arch Intern Med. 2006 Dec 11-25;166(22):2484-9
references.pmid: 17159014